Skip to main content
Elsevier

Journals in Biotechnology in health care

  • Journal of Immunological Methods

    • ISSN: 0022-1759
    The Journal of Immunological Methods is devoted to covering techniques for:(1) Quantitating and detecting antibodies and/or antigens. (2) Purifying immunoglobulins, lymphokines and other molecules of the immune system. (3) Isolating antigens and other substances important in immunological processes. (4) Labelling antigens and antibodies. (5) Localizing antigens and/or antibodies in tissues and cells. (6) Detecting, and fractionating immunocompetent cells. (7) Assaying for cellular immunity. (8) Documenting cell-cell interactions. (9) Initiating immunity and unresponsiveness. (10) Transplanting tissues. (11) Studying items closely related to immunity such as complement, reticuloendothelial system and others. (12) Molecular techniques for studying immune cells and their receptors. (13) Imaging of the immune system. (14) Methods for production or their fragments in eukaryotic and prokaryotic cells. (15) Computational methods including statistical and mathematical methods and computational models for analysis, visualization, and interpretation of results.Submitted full length manuscripts should describe new methods of broad applicability to immunology and not simply the application of an established method - although papers describing such applications may be considered for publication as a short Technical Note. Review articles will also be published by the Journal of Immunological Methods, but these manuscripts are by invitation only.
    Subscriptions

  • Journal of Microbiological Methods

    • ISSN: 0167-7012
    The Journal of Microbiological Methods publishes Research, Review and Short Communication articles on novel, state-of-the-art, and significantly improved methodologies in microbiology. Innovative, validated applications of existing methods that advance the field are also welcome. JMM considers research on all types of microorganisms including protozoa, fungi, bacteria, and viruses. Data must clearly support method interpretation and utility.The scope includes, but is not limited to:· Environmental, Agricultural & Ecological Microbiology: Applied and environmental microbiology, microbial ecology and diversity, soil/sediment/geomic... microbiomes, rumen microbiology, and methods for extreme environments including space missions.· Genetics, Molecular & Cellular Microbiology: Microbial genetics, genomics, molecular microbiology, physiology, ultrastructure, imaging, high-throughput sequencing, omics technologies (metabolomics, metagenomics, proteomics, transcriptomics), bioinformatics, and mathematical modeling.· Clinical, Medical, Veterinary & Public Health Microbiology: Diagnostics, clinical and veterinary microbiology, public health, vaccine development, sero-diagnostics, immunology, typing, and microbial identification.· Microbial Interactions & Pathogenesis: Host-pathogen interactions, microbiome interactions, plant-microbe relationships, parasitology, and mycology.· Virology: Innovative approaches for virus detection, isolation, quantification, and characterization, including molecular techniques, cell culture assays, viral genomics, imaging technologies, and high-throughput screening methods.· Technological Advances & Method Development: Bioassays, biosensors biochemical methods, sampling techniques, robotics, and radioisotope applications in microbiology.· Food Microbiology: Studies on the role of microorganisms in food production, preservation, spoilage, and foodborne illnesses.· Industrial Microbiology: Explores the industrial applications of microorganisms, such as in the production of pharmaceuticals, enzymes, and biofuels.· Mathematical modelling, computer science, and artificial intelligence techniques.We invite proposals for review articles and special issues on emerging microbiological methods driving scientific progress.
    Subscriptions

  • Biomaterials

    • ISSN: 0142-9612
    Biomaterials is an international journal covering the science and clinical application of biomaterials. A biomaterial is now defined as a substance that has been engineered to take a form which, alone or as part of a complex system, is used to direct, by control of interactions with components of living systems, the course of any therapeutic or diagnostic procedure. It is the aim of the journal to provide a peer-reviewed forum for the publication of original papers and authoritative review and opinion papers dealing with the most important issues facing the use of biomaterials in clinical practice. The scope of the journal covers the wide range of physical, biological and chemical sciences that underpin the design of biomaterials and the clinical disciplines in which they are used. These sciences include polymer synthesis and characterization, drug and gene vector design, the biology of the host response, immunology and toxicology and self assembly at the nanoscale. Clinical applications include the therapies of medical technology and regenerative medicine in all clinical disciplines, and diagnostic systems that reply on innovative contrast and sensing agents. The journal is relevant to areas such as cancer diagnosis and therapy, implantable devices, drug delivery systems, gene vectors, bionanotechnology and tissue engineering.Click here for New Editorial Instructions.
    Subscriptions

  • Journal of Biotechnology

    • ISSN: 0168-1656
    The Journal of Biotechnology (J. Biotech.) offers publication for both full-length articles and short communications on a wide range of biotechnology-relate... topics. Also, review articles can be submitted if they are pre-approved by one of the editors. The journal will only accept submissions with novel scientific research results that are directly relevant to biotechnological systems and/or applications (for details, please see the list below). J. Biotech. has strict rules about plagiarism. Any submission that includes parts of already published material will be rejected. This includes any attempt to re-publish already published Materials and Methods paragraphs. The journal features a "one-pass review process," i.e., eligible submissions will be reviewed, and those that need improvements (either minor or major) can be resubmitted only once before the decision about whether to accept or reject is decided by the Chief Editor. All figures need to be submitted as high-resolution files during the initial submission. All articles must be written in English, and the quality of the English language will be one of the criteria during the review process.Main Scope of the Journal:Bioprocess engineeringSystem biology, synthetic microbiologyMetaboli... engineering, microbial physiologyBiorefiner... biomass engineeringBiochemic... enzyme/protein engineeringMetabolic engineeringMicrobial expression systemsBiocatalyst engineeringInsect cell-based modelsMultienzyme cascade reactionsPlant-based biotechnologyOutside of the Scope:Manuscripts lacking noveltyReview articles submitted without previous invitation/confirmat... by an editorEnvironmental-... subjects, e.g., waste-water treatment, bioremediation, biodegradationReport... on the cloning and/or expression of naturally occurring enzymes without direct biotechnological applicationResearch on natural products without biotechnological modificationToxicolo... researchPharmacologi... researchFood science-related research without biotechnological applicationEngineeri... articles that do not deal with the direct improvement of biotechnological processesGenome research, especially genome sequencing reports
    Subscriptions

  • International Journal of Antimicrobial Agents

    • ISSN: 0924-8579
    Official journal of the International Society of Antimicrobial ChemotherapyThe International Journal of Antimicrobial Agents provides comprehensive and up-to-date peer reviewed reference information on the physical, pharmacological, in vitro and clinical properties of individual antimicrobial agents (antiviral agents, antiparasitic agents, antibacterial agents, antifungal agents, etc.). In addition, the journal signals new trends and developments in the field through highly authoritative review articles on antimicrobial agents. Special attention is given to articles providing insight into the problems of antimicrobial resistance both in the hospital and in the community. Both solicited reviews by top experts in the mentioned fields and high-quality original research papers are published.Additional information on the ISAC and its activities can be found at the ISAC Web site at: https://www.isac.wor...
    Subscriptions

  • Journal of Biomedical Informatics

    • ISSN: 1532-0464
    Endorsed by the American Medical Informatics AssociationThe Journal of Biomedical Informatics (JBI) is the premier methodology journal in the field of biomedical informatics. JBI publishes research on new methodologies and techniques that have general applicability and form the basis for the evolving science of biomedical informatics. Papers should focus on a real-world biomedical or clinical problem, develop a novel approach to address the problem, and evaluate its appropriateness in comparison to the current state-of-the-art (SoA) methods. Involvement of healthcare professionals in motivating the work and evaluation of results is expected.Focus Areas and Topics of InterestJBI seeks to publish papers that make a conceptual contribution to the field, typically by describing an innovation in methodology or technique or by discussing substantive generalizable lessons that have been learned in the context of an informatics project. When a methodological contribution has a theoretical basis, that theory is an appropriate emphasis for papers as well. Research papers may also present a novel "method of methods" explaining how to apply the existing methods to a space of biomedical problems that share unique characteristics influencing the choice of methods.JBI publishes papers on a wide range of informatics topics. However, across these topics, papers must build on deep understanding and utilization of medical domain knowledge and should consider pragmatic translation for clinical care or applications. Topics of interest include (but are not limited to) clinical decision support, patient safety, natural language processing, artificial intelligence and machine learning, knowledge representation for healthcare, translational bioinformatics, clinical research informatics, and clinical informatics. Additional considerations for papers in the areas of translational bioinformatics, machine learning, security and privacy are provided below. Irrespective of the topic, papers must focus on novel informatics methods and its comparison to the current approaches.Manuscrip... can be submitted in the following categories: original research, methodological review, commentaries, special communication, letters to the editor, book reviews, and editorials (see additional details on each of these categories below). Given the international readership of JBI, country-specific health systems or approaches will be considered only if they offer generalizable lessons that are relevant to the broader readership, regardless of their country, language, culture, or health system.Specific considerations for manuscripts in certain topical areas have also been provided in recent editorials.If you are considering an article with a focus on translational bioinformatics , please read this editorial. Biologic discoveries based on the use of routine informatics techniques may be important biologic contributions, but are not suitable for JBI. In addition, please note that JBI publishes bioinformatics papers only if they deal with issues in translational (human) science (e.g., translational bioinformatics papers).If you are considering an article describing a new machine learning approach, please read this editorial. Machine learning papers would be considered only if the methods that are introduced demonstrate substantial novelty and advancement beyond the current SoA and their evaluation is sound and includes an assessment of the potential of the method to be used in clinical practice. For example, submissions reporting publishing marginally SoA findings without an in-depth analysis or discussion of how the methods are potentially generalizable (or applicable in a wider setting) would not be considered. Novel and important clinical problems addressed by existing machine learning methods may warrant Special Communication papers if their discussion includes novel insights or lessons learned for future research in such domains.Authors considering an article on biomedical privacy and security, please read this editorial. To be considered, the privacy and security methods that are introduced should demonstrate substantial novelty and advancement beyond the SoA, should be specific to the biomedical informatics domain, and their practical application and/or likely real-world usefulness in the biomedical domain.Please note that papers related to signal processing, imaging, medical devices, or communication networks are outside the scope of the journal unless they combine knowledge-intensive approaches involving ontologies.Please also consult the editorial that explains where to direct Artificial Intelligence in Medicine-related manuscripts for peer review and possible publication, considering the different scope of the three Elsevier medical informatics journals: JBI, Artificial Intelligence in Medicine, and Intelligence-based Medicine.
    Subscriptions